Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Derek Archila's Stock Ratings
Wells Fargo Analyst
Derek Archila is an analyst at Wells Fargo. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/02/2025
Overall Average Return
4.73%
Smart Score
Overall Average Return Percentile
51st
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 04/30/2025 | INCY | Buy Now | Incyte | $62.16 | -5.08% | Derek Archila60% | $58 → $59 | Maintains | Equal-Weight | Get Alert |
| 04/09/2025 | NRIX | Buy Now | Nurix Therapeutics | $11.16 | 124.01% | Derek Archila60% | $32 → $25 | Maintains | Overweight | Get Alert |
| 04/07/2025 | RYTM | Buy Now | Rhythm Pharmaceuticals | $63.80 | 42.63% | Derek Archila60% | $80 → $91 | Maintains | Overweight | Get Alert |
| 04/01/2025 | CABA | Buy Now | Cabaletta Bio | $1.25 | 140% | Derek Archila60% | $6 → $3 | Maintains | Equal-Weight | Get Alert |
| 03/28/2025 | SEPN | Buy Now | Septerna | $7.14 | 54.06% | Derek Archila60% | $14 → $11 | Maintains | Equal-Weight | Get Alert |
| 03/21/2025 | GLUE | Buy Now | Monte Rosa Therapeutics | $4.90 | 104.08% | Derek Archila60% | $11 → $10 | Maintains | Equal-Weight | Get Alert |
| 03/12/2025 | ARVN | Buy Now | Arvinas | $7.18 | 262.12% | Derek Archila60% | $60 → $26 | Maintains | Overweight | Get Alert |
| 03/12/2025 | QTTB | Buy Now | Q32 Bio | $1.51 | 893.38% | Derek Archila60% | $16 → $15 | Maintains | Equal-Weight | Get Alert |
| 02/28/2025 | ARGX | Buy Now | argenx | $639.90 | 15.8% | Derek Archila60% | $723 → $741 | Maintains | Overweight | Get Alert |
| 02/24/2025 | EXEL | Buy Now | Exelixis | $38.89 | -7.43% | Derek Archila60% | $36 → $36 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 02/18/2025 | SEPN | Buy Now | Septerna | $7.14 | 96.08% | Derek Archila60% | $43 → $14 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 02/13/2025 | ANAB | Buy Now | AnaptysBio | $21.70 | 135.02% | Derek Archila60% | $40 → $51 | Maintains | Overweight | Get Alert |
| 01/30/2025 | ZNTL | Buy Now | Zentalis Pharma | $1.45 | 313.79% | Derek Archila60% | $8 → $6 | Maintains | Equal-Weight | Get Alert |
| 12/19/2024 | ARGX | Buy Now | argenx | $639.90 | 12.99% | Derek Archila60% | $639 → $723 | Maintains | Overweight | Get Alert |
| 12/19/2024 | ZYME | Buy Now | Zymeworks | $12.88 | 8.7% | Derek Archila60% | $12 → $14 | Maintains | Equal-Weight | Get Alert |
| 12/19/2024 | KZR | Buy Now | Kezar Life Sciences | $4.36 | 106.37% | Derek Archila60% | $11 → $9 | Maintains | Equal-Weight | Get Alert |
| 12/19/2024 | INCY | Buy Now | Incyte | $62.16 | 12.61% | Derek Archila60% | $68 → $70 | Maintains | Equal-Weight | Get Alert |
| 12/19/2024 | IMVT | Buy Now | Immunovant | $16.02 | 180.9% | Derek Archila60% | $47 → $45 | Maintains | Overweight | Get Alert |
| 12/19/2024 | CABA | Buy Now | Cabaletta Bio | $1.25 | 380% | Derek Archila60% | $12 → $6 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 12/19/2024 | CCCC | Buy Now | C4 Therapeutics | $1.58 | 659.25% | Derek Archila60% | $8 → $12 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 12/19/2024 | GLUE | Buy Now | Monte Rosa Therapeutics | $4.90 | 124.49% | Derek Archila60% | $14 → $11 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 12/19/2024 | VRDN | Buy Now | Viridian Therapeutics | $13.55 | 99.26% | Derek Archila60% | → $27 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 12/12/2024 | ANAB | Buy Now | AnaptysBio | $21.70 | 84.33% | Derek Archila60% | $56 → $40 | Maintains | Overweight | Get Alert |
| 12/11/2024 | SLRN | Buy Now | Acelyrin | $2.29 | 467.41% | Derek Archila60% | $15 → $13 | Maintains | Overweight | Get Alert |
| 12/11/2024 | QTTB | Buy Now | Q32 Bio | $1.51 | 959.6% | Derek Archila60% | $95 → $16 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 12/02/2024 | KYMR | Buy Now | Kymera Therapeutics | $34.55 | 64.98% | Derek Archila60% | $38 → $57 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 11/19/2024 | SEPN | Buy Now | Septerna | $7.14 | 502.24% | Derek Archila60% | → $43 | Initiates | → Overweight | Get Alert |
| 11/15/2024 | CABA | Buy Now | Cabaletta Bio | $1.25 | 860% | Derek Archila60% | $20 → $12 | Maintains | Overweight | Get Alert |
| 11/15/2024 | KYTX | Buy Now | Kyverna Therapeutics | $2.12 | 1032.02% | Derek Archila60% | $44 → $24 | Maintains | Overweight | Get Alert |
| 11/14/2024 | KZR | Buy Now | Kezar Life Sciences | $4.36 | 152.24% | Derek Archila60% | $20 → $11 | Maintains | Equal-Weight | Get Alert |
| 11/06/2024 | APLS | Buy Now | Apellis Pharmaceuticals | $20.08 | 49.4% | Derek Archila60% | $43 → $30 | Maintains | Equal-Weight | Get Alert |
| 11/01/2024 | ARGX | Buy Now | argenx | $639.90 | -0.14% | Derek Archila60% | $547 → $639 | Maintains | Overweight | Get Alert |
| 11/01/2024 | ZYME | Buy Now | Zymeworks | $12.88 | -6.83% | Derek Archila60% | $12 → $12 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 10/31/2024 | BPMC | Buy Now | Blueprint Medicines | $99.25 | 52.14% | Derek Archila60% | $153 → $151 | Maintains | Overweight | Get Alert |
| 10/30/2024 | INCY | Buy Now | Incyte | $62.16 | 9.4% | Derek Archila60% | $62 → $68 | Maintains | Equal-Weight | Get Alert |
| 10/30/2024 | EXEL | Buy Now | Exelixis | $38.89 | -7.43% | Derek Archila60% | $32 → $36 | Maintains | Overweight | Get Alert |
| 10/16/2024 | SLRN | Buy Now | Acelyrin | $2.29 | 554.71% | Derek Archila60% | $13 → $15 | Maintains | Overweight | Get Alert |
| 10/10/2024 | INCY | Buy Now | Incyte | $62.16 | -0.26% | Derek Archila60% | $63 → $62 | Maintains | Equal-Weight | Get Alert |
| 10/04/2024 | ATYR | Buy Now | aTyr Pharma | $3.40 | 400% | Derek Archila60% | → $17 | Initiates | → Overweight | Get Alert |
| 09/24/2024 | APLS | Buy Now | Apellis Pharmaceuticals | $20.08 | 114.14% | Derek Archila60% | $47 → $43 | Maintains | Equal-Weight | Get Alert |
| 09/17/2024 | ASND | Buy Now | Ascendis Pharma | $172.00 | 68.02% | Derek Archila60% | $264 → $289 | Maintains | Overweight | Get Alert |
| 09/04/2024 | ASND | Buy Now | Ascendis Pharma | $172.00 | 53.49% | Derek Archila60% | $277 → $264 | Maintains | Overweight | Get Alert |
| 08/12/2024 | VTYX | Buy Now | Ventyx Biosciences | $1.39 | 691.42% | Derek Archila60% | $16 → $11 | Maintains | Overweight | Get Alert |
| 08/12/2024 | CLDX | Buy Now | Celldex Therapeutics | $20.71 | 78.66% | Derek Archila60% | $35 → $37 | Maintains | Equal-Weight | Get Alert |
| 08/12/2024 | KYMR | Buy Now | Kymera Therapeutics | $34.55 | 9.99% | Derek Archila60% | $30 → $38 | Maintains | Equal-Weight | Get Alert |
| 08/12/2024 | CABA | Buy Now | Cabaletta Bio | $1.25 | 1500% | Derek Archila60% | $35 → $20 | Maintains | Overweight | Get Alert |
| 08/12/2024 | GLUE | Buy Now | Monte Rosa Therapeutics | $4.90 | 246.94% | Derek Archila60% | $18 → $17 | Maintains | Overweight | Get Alert |
| 07/26/2024 | ARGX | Buy Now | argenx | $639.90 | -14.52% | Derek Archila60% | $543 → $547 | Maintains | Overweight | Get Alert |
| 07/08/2024 | SLRN | Buy Now | Acelyrin | $2.29 | 467.41% | Derek Archila60% | $13 → $13 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 06/24/2024 | ARGX | Buy Now | argenx | $639.90 | -15.3% | Derek Archila60% | $478 → $542 | Maintains | Overweight | Get Alert |
| 06/18/2024 | ZNTL | Buy Now | Zentalis Pharma | $1.45 | 520.69% | Derek Archila60% | $29 → $9 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 05/23/2024 | APLS | Buy Now | Apellis Pharmaceuticals | $20.08 | 139.04% | Derek Archila60% | $57 → $48 | Maintains | Equal-Weight | Get Alert |
| 05/15/2024 | ANNX | Buy Now | Annexon | $1.85 | 440.54% | Derek Archila60% | $12 → $10 | Maintains | Overweight | Get Alert |
| 05/09/2024 | CCCC | Buy Now | C4 Therapeutics | $1.58 | 406.17% | Derek Archila60% | $7 → $8 | Maintains | Equal-Weight | Get Alert |
| 05/09/2024 | ARVN | Buy Now | Arvinas | $7.18 | 735.65% | Derek Archila60% | $63 → $60 | Maintains | Overweight | Get Alert |
| 05/03/2024 | ZYME | Buy Now | Zymeworks | $12.88 | -6.83% | Derek Archila60% | $14 → $12 | Maintains | Overweight | Get Alert |
| 05/03/2024 | ASND | Buy Now | Ascendis Pharma | $172.00 | 52.33% | Derek Archila60% | $260 → $262 | Maintains | Overweight | Get Alert |
| 04/18/2024 | RYTM | Buy Now | Rhythm Pharmaceuticals | $63.80 | -18.5% | Derek Archila60% | $53 → $52 | Maintains | Overweight | Get Alert |
| 04/11/2024 | ANAB | Buy Now | AnaptysBio | $21.70 | 158.06% | Derek Archila60% | → $56 | Initiates | → Overweight | Get Alert |
| 04/01/2024 | ANNX | Buy Now | Annexon | $1.85 | 548.65% | Derek Archila60% | $12 → $12 | Maintains | Overweight | Get Alert |
| 03/27/2024 | ANNX | Buy Now | Annexon | $1.85 | 548.65% | Derek Archila60% | $11 → $12 | Maintains | Overweight | Get Alert |
| 03/22/2024 | CABA | Buy Now | Cabaletta Bio | $1.25 | 2700% | Derek Archila60% | $34 → $35 | Maintains | Overweight | Get Alert |
| 03/21/2024 | SLRN | Buy Now | Acelyrin | $2.29 | 467.41% | Derek Archila60% | $11 → $13 | Maintains | Equal-Weight | Get Alert |
| 03/15/2024 | ASND | Buy Now | Ascendis Pharma | $172.00 | 51.16% | Derek Archila60% | $196 → $260 | Maintains | Overweight | Get Alert |
| 03/14/2024 | MOR | Buy Now | MorphoSys | — | — | Derek Archila60% | $17 → $18.25 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 03/12/2024 | ZYME | Buy Now | Zymeworks | $12.88 | 8.7% | Derek Archila60% | $12 → $14 | Maintains | Overweight | Get Alert |
| 03/12/2024 | VTYX | Buy Now | Ventyx Biosciences | $1.39 | 1051.16% | Derek Archila60% | $7 → $16 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 02/20/2024 | ARGX | Buy Now | argenx | $639.90 | -25.3% | Derek Archila60% | $472 → $478 | Maintains | Overweight | Get Alert |
| 02/16/2024 | NRIX | Buy Now | Nurix Therapeutics | $11.16 | 79.21% | Derek Archila60% | $23 → $20 | Maintains | Overweight | Get Alert |
| 02/05/2024 | MOR | Buy Now | MorphoSys | — | — | Derek Archila60% | → $17 | Reiterates | Overweight → Overweight | Get Alert |
| 12/21/2023 | ARGX | Buy Now | argenx | $639.90 | -26.55% | Derek Archila60% | $585 → $470 | Maintains | Overweight | Get Alert |
| 12/19/2023 | KYMR | Buy Now | Kymera Therapeutics | $34.55 | -24.75% | Derek Archila60% | → $26 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 12/19/2023 | VTYX | Buy Now | Ventyx Biosciences | $1.39 | 115.84% | Derek Archila60% | $8 → $3 | Maintains | Equal-Weight | Get Alert |
| 12/19/2023 | RYTM | Buy Now | Rhythm Pharmaceuticals | $63.80 | -16.93% | Derek Archila60% | $48 → $53 | Maintains | Overweight | Get Alert |
| 12/19/2023 | BPMC | Buy Now | Blueprint Medicines | $99.25 | 15.87% | Derek Archila60% | $86 → $115 | Maintains | Overweight | Get Alert |
| 12/19/2023 | ASND | Buy Now | Ascendis Pharma | $172.00 | -13.37% | Derek Archila60% | $137 → $149 | Maintains | Overweight | Get Alert |
| 12/19/2023 | ARVN | Buy Now | Arvinas | $7.18 | 777.44% | Derek Archila60% | → $63 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 12/15/2023 | MOR | Buy Now | MorphoSys | — | — | Derek Archila60% | $10 → $17 | Maintains | Overweight | Get Alert |
| 12/14/2023 | APLS | Buy Now | Apellis Pharmaceuticals | $20.08 | 168.92% | Derek Archila60% | $67 → $54 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 12/13/2023 | SLRN | Buy Now | Acelyrin | $2.29 | 380.12% | Derek Archila60% | → $11 | Initiates | → Equal-Weight | Get Alert |
| 11/14/2023 | KZR | Buy Now | Kezar Life Sciences | $4.36 | -54.14% | Derek Archila60% | $40 → $20 | Maintains | Equal-Weight | Get Alert |
| 11/10/2023 | CABA | Buy Now | Cabaletta Bio | $1.25 | 2620% | Derek Archila60% | $39 → $34 | Maintains | Overweight | Get Alert |
| 11/10/2023 | CLDX | Buy Now | Celldex Therapeutics | $20.71 | 30.37% | Derek Archila60% | → $27 | Upgrade | Underweight → Equal-Weight | Get Alert |
| 11/08/2023 | RYTM | Buy Now | Rhythm Pharmaceuticals | $63.80 | -37.3% | Derek Archila60% | $38 → $40 | Maintains | Overweight | Get Alert |
| 09/27/2023 | IMVT | Buy Now | Immunovant | $16.02 | 199.63% | Derek Archila60% | $33 → $48 | Maintains | Overweight | Get Alert |
| 09/18/2023 | CABA | Buy Now | Cabaletta Bio | $1.25 | 3020% | Derek Archila60% | $14 → $39 | Maintains | Overweight | Get Alert |
| 09/15/2023 | APLS | Buy Now | Apellis Pharmaceuticals | $20.08 | 218.73% | Derek Archila60% | $34 → $64 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 09/06/2023 | ASND | Buy Now | Ascendis Pharma | $172.00 | -22.09% | Derek Archila60% | $139 → $134 | Maintains | Overweight | Get Alert |
| 08/22/2023 | CLDX | Buy Now | Celldex Therapeutics | $20.71 | 1.4% | Derek Archila60% | → $21 | Initiates | → Underweight | Get Alert |
| 08/11/2023 | KZR | Buy Now | Kezar Life Sciences | $4.36 | — | Derek Archila60% | — | Downgrade | Overweight → Equal-Weight | Get Alert |
| 08/10/2023 | ZNTL | Buy Now | Zentalis Pharma | $1.45 | 3348.28% | Derek Archila60% | $51 → $50 | Maintains | Overweight | Get Alert |
| 07/31/2023 | BPMC | Buy Now | Blueprint Medicines | $99.25 | — | Derek Archila60% | $55 → $83 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 07/28/2023 | ARGX | Buy Now | argenx | $639.90 | -4.83% | Derek Archila60% | $606 → $609 | Maintains | Overweight | Get Alert |
| 07/24/2023 | IMVT | Buy Now | Immunovant | $16.02 | 105.99% | Derek Archila60% | $27 → $33 | Maintains | Overweight | Get Alert |
| 07/20/2023 | APLS | Buy Now | Apellis Pharmaceuticals | $20.08 | 163.94% | Derek Archila60% | $76 → $53 | Maintains | Equal-Weight | Get Alert |
| 06/20/2023 | DICE | Buy Now | DICE Therapeutics | — | — | Derek Archila60% | $38 → $48 | Maintains | Equal-Weight | Get Alert |
| 06/16/2023 | MOR | Buy Now | MorphoSys | — | — | Derek Archila60% | → $17 | Initiates | → Overweight | Get Alert |
| 06/14/2023 | BPMC | Buy Now | Blueprint Medicines | $99.25 | -44.58% | Derek Archila60% | $48 → $55 | Maintains | Equal-Weight | Get Alert |
| 05/24/2023 | DICE | Buy Now | DICE Therapeutics | — | — | Derek Archila60% | → $38 | Initiates | → Equal-Weight | Get Alert |
| 05/23/2023 | BPMC | Buy Now | Blueprint Medicines | $99.25 | -51.64% | Derek Archila60% | $47 → $48 | Maintains | Equal-Weight | Get Alert |
| 05/12/2023 | KZR | Buy Now | Kezar Life Sciences | $4.36 | 198.1% | Derek Archila60% | $140 → $130 | Maintains | Overweight | Get Alert |
| 05/05/2023 | APLS | Buy Now | Apellis Pharmaceuticals | $20.08 | 278.49% | Derek Archila60% | $55 → $76 | Maintains | Equal-Weight | Get Alert |
| 04/25/2023 | MORF | Buy Now | Morphic Holding | — | — | Derek Archila60% | $67 → $80 | Maintains | Overweight | Get Alert |
| 03/21/2023 | ZYME | Buy Now | Zymeworks | $12.88 | -6.83% | Derek Archila60% | → $12 | Assumes | → Overweight | Get Alert |
| 03/21/2023 | VTYX | Buy Now | Ventyx Biosciences | $1.39 | 5439.97% | Derek Archila60% | → $77 | Initiates | → Overweight | Get Alert |
| 03/09/2023 | EXEL | Buy Now | Exelixis | $38.89 | -40.86% | Derek Archila60% | → $23 | Initiates | → Overweight | Get Alert |
| 01/03/2023 | KYMR | Buy Now | Kymera Therapeutics | $34.55 | 21.56% | Derek Archila60% | $40 → $42 | Maintains | Overweight | Get Alert |
| 01/03/2023 | KZR | Buy Now | Kezar Life Sciences | $4.36 | 221.03% | Derek Archila60% | $170 → $140 | Maintains | Overweight | Get Alert |
| 01/03/2023 | INCY | Buy Now | Incyte | $62.16 | 20.66% | Derek Archila60% | $72 → $75 | Maintains | Equal-Weight | Get Alert |
| 01/03/2023 | CABA | Buy Now | Cabaletta Bio | $1.25 | 1020% | Derek Archila60% | $4 → $14 | Maintains | Overweight | Get Alert |
| 01/03/2023 | CCCC | Buy Now | C4 Therapeutics | $1.58 | 469.44% | Derek Archila60% | $11 → $9 | Maintains | Equal-Weight | Get Alert |
| 01/03/2023 | ASND | Buy Now | Ascendis Pharma | $172.00 | 2.91% | Derek Archila60% | $169 → $177 | Maintains | Overweight | Get Alert |
| 01/03/2023 | APLS | Buy Now | Apellis Pharmaceuticals | $20.08 | 188.84% | Derek Archila60% | → $58 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 01/03/2023 | ARVN | Buy Now | Arvinas | $7.18 | 582.45% | Derek Archila60% | $83 → $49 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 01/03/2023 | GLUE | Buy Now | Monte Rosa Therapeutics | $4.90 | 287.76% | Derek Archila60% | → $19 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 01/03/2023 | BPMC | Buy Now | Blueprint Medicines | $99.25 | -58.69% | Derek Archila60% | → $41 | Upgrade | Underweight → Equal-Weight | Get Alert |
| 01/03/2023 | IMVT | Buy Now | Immunovant | $16.02 | 68.54% | Derek Archila60% | $10 → $27 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 12/13/2022 | HZNP | Buy Now | Horizon Therapeutics | — | — | Derek Archila60% | $118 → $116.5 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 11/08/2022 | MORF | Buy Now | Morphic Holding | — | — | Derek Archila60% | $77 → $78 | Maintains | Overweight | Get Alert |
| 11/08/2022 | KYMR | Buy Now | Kymera Therapeutics | $34.55 | 4.2% | Derek Archila60% | $35 → $36 | Maintains | Overweight | Get Alert |
| 11/08/2022 | IMVT | Buy Now | Immunovant | $16.02 | -37.58% | Derek Archila60% | $7 → $10 | Maintains | Equal-Weight | Get Alert |
| 11/08/2022 | CCCC | Buy Now | C4 Therapeutics | $1.58 | 595.98% | Derek Archila60% | $12 → $11 | Maintains | Equal-Weight | Get Alert |
| 11/07/2022 | ASND | Buy Now | Ascendis Pharma | $172.00 | -1.74% | Derek Archila60% | $172 → $169 | Maintains | Overweight | Get Alert |
| 10/18/2022 | ARGX | Buy Now | argenx | $639.90 | -26.71% | Derek Archila60% | $461 → $469 | Maintains | Overweight | Get Alert |
| 10/18/2022 | INCY | Buy Now | Incyte | $62.16 | 20.66% | Derek Archila60% | $76 → $75 | Maintains | Equal-Weight | Get Alert |
| 09/22/2022 | ASND | Buy Now | Ascendis Pharma | $172.00 | — | Derek Archila60% | $167 → $172 | Maintains | Overweight | Get Alert |
| 09/14/2022 | CABA | Buy Now | Cabaletta Bio | $1.25 | 220% | Derek Archila60% | $14 → $4 | Maintains | Overweight | Get Alert |
| 08/29/2022 | RXDX | Buy Now | Prometheus Biosciences | — | — | Derek Archila60% | $51 → $71 | Maintains | Overweight | Get Alert |
| 08/17/2022 | BPMC | Buy Now | Blueprint Medicines | $99.25 | -58.69% | Derek Archila60% | $40 → $41 | Maintains | Underweight | Get Alert |
| 08/04/2022 | MORF | Buy Now | Morphic Holding | — | — | Derek Archila60% | $79 → $77 | Maintains | Overweight | Get Alert |
| 07/28/2022 | INCY | Buy Now | Incyte | $62.16 | 22.27% | Derek Archila60% | → $76 | Initiates | → Equal-Weight | Get Alert |
| 06/28/2022 | KZR | Buy Now | Kezar Life Sciences | $4.36 | 289.82% | Derek Archila60% | $130 → $170 | Maintains | Overweight | Get Alert |
| 06/27/2022 | BPMC | Buy Now | Blueprint Medicines | $99.25 | -59.7% | Derek Archila60% | → $40 | Initiates | → Underweight | Get Alert |
| 06/01/2022 | KYMR | Buy Now | Kymera Therapeutics | $34.55 | 1.3% | Derek Archila60% | $62 → $35 | Maintains | Overweight | Get Alert |
| 05/31/2022 | NRIX | Buy Now | Nurix Therapeutics | $11.16 | 124.01% | Derek Archila60% | → $25 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 05/13/2022 | RXDX | Buy Now | Prometheus Biosciences | — | — | Derek Archila60% | $53 → $51 | Maintains | Overweight | Get Alert |
| 05/13/2022 | KZR | Buy Now | Kezar Life Sciences | $4.36 | 198.1% | Derek Archila60% | $140 → $130 | Maintains | Overweight | Get Alert |
| 05/12/2022 | ASND | Buy Now | Ascendis Pharma | $172.00 | 2.33% | Derek Archila60% | $190 → $176 | Maintains | Overweight | Get Alert |
| 05/05/2022 | MORF | Buy Now | Morphic Holding | — | — | Derek Archila60% | $81 → $79 | Maintains | Overweight | Get Alert |
| 05/04/2022 | KZR | Buy Now | Kezar Life Sciences | $4.36 | 221.03% | Derek Archila60% | $190 → $140 | Maintains | Overweight | Get Alert |
| 04/11/2022 | NRIX | Buy Now | Nurix Therapeutics | $11.16 | 124.01% | Derek Archila60% | $28 → $25 | Maintains | Equal-Weight | Get Alert |
| 04/06/2022 | ZNTL | Buy Now | Zentalis Pharma | $1.45 | 4520.69% | Derek Archila60% | → $67 | Initiates | → Overweight | Get Alert |
| 03/10/2022 | RXDX | Buy Now | Prometheus Biosciences | — | — | Derek Archila60% | $42 → $53 | Maintains | Overweight | Get Alert |
| 03/03/2022 | ASND | Buy Now | Ascendis Pharma | $172.00 | -1.16% | Derek Archila60% | $176 → $170 | Maintains | Overweight | Get Alert |
| 02/10/2022 | KYMR | Buy Now | Kymera Therapeutics | $34.55 | 79.45% | Derek Archila60% | → $62 | Initiates | → Overweight | Get Alert |
| 02/10/2022 | NRIX | Buy Now | Nurix Therapeutics | $11.16 | 150.9% | Derek Archila60% | → $28 | Initiates | → Equal-Weight | Get Alert |
| 02/10/2022 | ARVN | Buy Now | Arvinas | $7.18 | 1264.9% | Derek Archila60% | → $98 | Initiates | → Overweight | Get Alert |
| 02/10/2022 | GLUE | Buy Now | Monte Rosa Therapeutics | $4.90 | 287.76% | Derek Archila60% | → $19 | Initiates | → Equal-Weight | Get Alert |
| 02/10/2022 | CCCC | Buy Now | C4 Therapeutics | $1.58 | 1481.78% | Derek Archila60% | → $25 | Initiates | → Equal-Weight | Get Alert |
| 12/20/2021 | ARGX | Buy Now | argenx | $639.90 | -38.27% | Derek Archila60% | $390 → $395 | Maintains | Overweight | Get Alert |
| 12/08/2021 | ARNA | Buy Now | Arena Pharmaceuticals | — | — | Derek Archila60% | → $71 | Initiates | → Overweight | Get Alert |
| 12/08/2021 | RYTM | Buy Now | Rhythm Pharmaceuticals | $63.80 | -52.98% | Derek Archila60% | → $30 | Initiates | → Overweight | Get Alert |
| 12/08/2021 | RXDX | Buy Now | Prometheus Biosciences | — | — | Derek Archila60% | → $42 | Initiates | → Overweight | Get Alert |
| 12/08/2021 | IMVT | Buy Now | Immunovant | $16.02 | -43.82% | Derek Archila60% | → $9 | Initiates | → Equal-Weight | Get Alert |
| 12/08/2021 | APLS | Buy Now | Apellis Pharmaceuticals | $20.08 | 318.33% | Derek Archila60% | → $84 | Initiates | → Overweight | Get Alert |
| 12/08/2021 | ARGX | Buy Now | argenx | $639.90 | -39.05% | Derek Archila60% | → $390 | Initiates | → Overweight | Get Alert |
| 12/08/2021 | ASND | Buy Now | Ascendis Pharma | $172.00 | 2.33% | Derek Archila60% | → $176 | Initiates | → Overweight | Get Alert |
| 12/08/2021 | CABA | Buy Now | Cabaletta Bio | $1.25 | 1260% | Derek Archila60% | → $17 | Initiates | → Overweight | Get Alert |
| 12/08/2021 | HZNP | Buy Now | Horizon Therapeutics | — | — | Derek Archila60% | → $137 | Initiates | → Overweight | Get Alert |
| 12/08/2021 | KZR | Buy Now | Kezar Life Sciences | $4.36 | 335.68% | Derek Archila60% | → $190 | Initiates | → Overweight | Get Alert |
| 12/08/2021 | MORF | Buy Now | Morphic Holding | — | — | Derek Archila60% | → $81 | Initiates | → Overweight | Get Alert |
| 06/01/2021 | IMVT | Buy Now | Immunovant | $16.02 | -43.82% | Derek Archila60% | $28 → $9 | Downgrade | Buy → Hold | Get Alert |
| 05/05/2021 | ESPR | Buy Now | Esperion Therapeutics | $0.98 | 1930.46% | Derek Archila60% | $37 → $20 | Downgrade | Buy → Hold | Get Alert |
| 04/06/2021 | RXDX | Buy Now | Prometheus Biosciences | — | — | Derek Archila60% | → $25 | Initiates | → Buy | Get Alert |
| 03/11/2021 | LUMO | Buy Now | Lumos Pharma | — | — | Derek Archila60% | $4 → $24 | Upgrade | Hold → Buy | Get Alert |
| 02/02/2021 | IMVT | Buy Now | Immunovant | $16.02 | 105.99% | Derek Archila60% | $54 → $33 | Maintains | Buy | Get Alert |
| 10/08/2020 | IMVT | Buy Now | Immunovant | $16.02 | 187.14% | Derek Archila60% | → $46 | Initiates | → Buy | Get Alert |
| 09/01/2020 | APLS | Buy Now | Apellis Pharmaceuticals | $20.08 | 99.2% | Derek Archila60% | → $40 | Initiates | → Buy | Get Alert |
| 08/20/2020 | MNTA | Buy Now | Momenta Pharmaceuticals | — | — | Derek Archila60% | $47 → $52.5 | Downgrade | Buy → Hold | Get Alert |
| 08/20/2020 | PRNB | Buy Now | Principia Biopharma | — | — | Derek Archila60% | $104 → $100 | Downgrade | Buy → Hold | Get Alert |
| 08/06/2020 | ARNA | Buy Now | Arena Pharmaceuticals | — | — | Derek Archila60% | $60 → $78 | Maintains | Overweight | Get Alert |
| 08/04/2020 | IVA | Buy Now | Inventiva | $3.78 | 376.19% | Derek Archila60% | → $18 | Initiates | → Buy | Get Alert |
| 07/23/2020 | GNFT | Buy Now | Genfit | $3.91 | — | Derek Archila60% | — | Upgrade | Hold → Buy | Get Alert |
| 07/10/2020 | GLPG | Buy Now | Galapagos | $26.78 | 620.69% | Derek Archila60% | $298 → $193 | Downgrade | Buy → Hold | Get Alert |
| 06/09/2020 | VIE | Buy Now | Viela Bio | — | — | Derek Archila60% | → $58 | Initiates | → Hold | Get Alert |
| 05/12/2020 | CBAY | Buy Now | CymaBay Therapeutics | — | — | Derek Archila60% | $4 → $8 | Upgrade | Hold → Buy | Get Alert |
| 04/15/2020 | OKE | Buy Now | ONEOK | $81.20 | -49.51% | Derek Archila60% | $61 → $41 | Reiterates | → Buy | Get Alert |
| 03/31/2020 | AMRN | Buy Now | Amarin Corp | $10.70 | -25.23% | Derek Archila60% | $480 → $160 | Maintains | Hold | Get Alert |
| 03/19/2020 | NGM | Buy Now | NGM Biopharmaceuticals | — | — | Derek Archila60% | $33 → $32 | Maintains | Buy | Get Alert |
| 03/17/2020 | DBVT | Buy Now | DBV Technologies | $8.75 | -31.43% | Derek Archila60% | $180 → $60 | Downgrade | Buy → Hold | Get Alert |
| 03/11/2020 | PRNB | Buy Now | Principia Biopharma | — | — | Derek Archila60% | $66 → $76 | Maintains | Buy | Get Alert |
| 02/25/2020 | NGM | Buy Now | NGM Biopharmaceuticals | — | — | Derek Archila60% | $26 → $33 | Maintains | Buy | Get Alert |
| 01/28/2020 | MNTA | Buy Now | Momenta Pharmaceuticals | — | — | Derek Archila60% | $29 → $43 | Maintains | Buy | Get Alert |
| 01/09/2020 | DBVT | Buy Now | DBV Technologies | $8.75 | 105.71% | Derek Archila60% | $100 → $180 | Upgrade | Hold → Buy | Get Alert |
| 12/19/2019 | PRNB | Buy Now | Principia Biopharma | — | — | Derek Archila60% | $51 → $66 | Maintains | Buy | Get Alert |
| 12/16/2019 | AMRN | Buy Now | Amarin Corp | $10.70 | 142.99% | Derek Archila60% | $560 → $520 | Downgrade | Buy → Hold | Get Alert |
| 11/25/2019 | CBAY | Buy Now | CymaBay Therapeutics | — | — | Derek Archila60% | — | Downgrade | Buy → Hold | Get Alert |
| 09/18/2019 | ESPR | Buy Now | Esperion Therapeutics | $0.98 | 7006.6% | Derek Archila60% | $112 → $70 | Maintains | Buy | Get Alert |
| 06/25/2019 | NGM | Buy Now | NGM Biopharmaceuticals | — | — | Derek Archila60% | → $26 | Initiates | → Buy | Get Alert |
| 06/25/2019 | CBAY | Buy Now | CymaBay Therapeutics | — | — | Derek Archila60% | → $14 | Initiates | → Buy | Get Alert |
| 04/17/2019 | PRNB | Buy Now | Principia Biopharma | — | — | Derek Archila60% | → $45 | Initiates | → Buy | Get Alert |
| 03/22/2019 | AMRN | Buy Now | Amarin Corp | $10.70 | 152.34% | Derek Archila60% | → $540 | Initiates | → Buy | Get Alert |
| 12/11/2018 | VNDA | Buy Now | Vanda Pharma | $4.45 | 551.69% | Derek Archila60% | → $29 | Downgrade | Outperform → Perform | Get Alert |
| 09/21/2018 | VNDA | Buy Now | Vanda Pharma | $4.45 | 551.69% | Derek Archila60% | $27 → $29 | Maintains | Outperform | Get Alert |
| 09/14/2018 | DBVT | Buy Now | DBV Technologies | $8.75 | 300% | Derek Archila60% | → $350 | Initiates | → Buy | Get Alert |
| 07/16/2018 | KZR | Buy Now | Kezar Life Sciences | $4.36 | 587.92% | Derek Archila60% | → $300 | Initiates | → Outperform | Get Alert |
| 06/22/2018 | HRTX | Buy Now | Heron Therapeutics | $2.26 | 2110.92% | Derek Archila60% | $34 → $50 | Maintains | Outperform | Get Alert |
| 01/03/2018 | ARNA | Buy Now | Arena Pharmaceuticals | — | — | Derek Archila60% | — | Upgrade | Market Perform → Outperform | Get Alert |
| 11/22/2017 | MNK | Buy Now | Mallinckrodt | — | — | Derek Archila60% | — | Downgrade | Outperform → Perform | Get Alert |
| 11/15/2017 | URGN | Buy Now | UroGen Pharma | $11.67 | 337.02% | Derek Archila60% | $32 → $51 | Maintains | Outperform | Get Alert |
| 10/31/2017 | HRTX | Buy Now | Heron Therapeutics | $2.26 | 1093.9% | Derek Archila60% | → $27 | Initiates | → Outperform | Get Alert |
| 10/30/2017 | VNDA | Buy Now | Vanda Pharma | $4.45 | 484.27% | Derek Archila60% | $21 → $26 | Maintains | Outperform | Get Alert |
| 09/07/2017 | PRGO | Buy Now | Perrigo | $25.27 | 248.24% | Derek Archila60% | → $88 | Initiates | → Outperform | Get Alert |
| 09/07/2017 | PCRX | Buy Now | Pacira BioSciences | $26.75 | — | Derek Archila60% | — | Initiates | → Market Perform | Get Alert |
| 08/15/2017 | ZYNE | Buy Now | Zynerba Pharmaceuticals | — | — | Derek Archila60% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 08/03/2017 | TEVA | Buy Now | Teva Pharmaceutical Indus | $15.80 | — | Derek Archila60% | — | Downgrade | Outperform → Perform | Get Alert |
| 04/12/2017 | VNDA | Buy Now | Vanda Pharma | $4.45 | — | Derek Archila60% | — | Initiates | → Outperform | Get Alert |
| 09/02/2016 | TEVA | Buy Now | Teva Pharmaceutical Indus | $15.80 | — | Derek Archila60% | — | Upgrade | Perform → Outperform | Get Alert |
| 02/25/2016 | ESPR | Buy Now | Esperion Therapeutics | $0.98 | 6397.46% | Derek Archila60% | $105 → $64 | Maintains | Buy | Get Alert |
| 11/12/2015 | ZYNE | Buy Now | Zynerba Pharmaceuticals | — | — | Derek Archila60% | $40 → $34 | Maintains | Outperform | Get Alert |
| 05/08/2015 | ESPR | Buy Now | Esperion Therapeutics | $0.98 | 11676.65% | Derek Archila60% | $106 → $116 | Maintains | Buy | Get Alert |
| 05/08/2015 | ESPR | Buy Now | Esperion Therapeutics | $0.98 | 11676.65% | Derek Archila60% | $106 → $116 | Maintains | Buy | Get Alert |
| 05/08/2015 | CBAY | Buy Now | CymaBay Therapeutics | — | — | Derek Archila60% | $15 → $19 | Maintains | Buy | Get Alert |
| 03/06/2015 | MNK | Buy Now | Mallinckrodt | — | — | Derek Archila60% | $122 → $140 | Maintains | Outperform | Get Alert |
| 02/23/2015 | ASND | Buy Now | Ascendis Pharma | $172.00 | — | Derek Archila60% | — | Initiates | → Outperform | Get Alert |
| 02/17/2015 | ESPR | Buy Now | Esperion Therapeutics | $0.98 | 9037.06% | Derek Archila60% | $60 → $90 | Maintains | Buy | Get Alert |
| 01/20/2015 | CBAY | Buy Now | CymaBay Therapeutics | — | — | Derek Archila60% | $10 → $15 | Maintains | Buy | Get Alert |
| 09/17/2014 | CBAY | Buy Now | CymaBay Therapeutics | — | — | Derek Archila60% | → $10 | Initiates | → Buy | Get Alert |
| 07/16/2014 | MNK | Buy Now | Mallinckrodt | — | — | Derek Archila60% | → $100 | Initiates | → Outperform | Get Alert |
| 07/22/2013 | ESPR | Buy Now | Esperion Therapeutics | $0.98 | 2336.55% | Derek Archila60% | → $24 | Initiates | → Buy | Get Alert |
